Get the Stockscreener App
2.92
0.69%
0.02
After Hours:
2.92
Koru Medical Systems Inc stock is traded at $2.92, with a volume of 247.43K.
It is up +0.69% in the last 24 hours and down -27.00% over the past month.
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
See More
Previous Close:
$2.90
Open:
$2.91
24h Volume:
247.43K
Relative Volume:
1.32
Market Cap:
$134.19M
Revenue:
$31.99M
Net Income/Loss:
$-11.97M
P/E Ratio:
-11.68
EPS:
-0.25
Net Cash Flow:
$-1.75M
1W Performance:
-10.98%
1M Performance:
-27.00%
6M Performance:
+13.62%
1Y Performance:
+41.75%
1-Day Range:
$2.78
$2.95
1-Week Range:
$2.56
$3.15
52-Week Range:
$2.05
$5.05
Koru Medical Systems Inc Stock (KRMD) Company Profile
Name
Koru Medical Systems Inc
Sector
Industry
Phone
845-469-2042
Address
100 CORPORATE DRIVE, MAHWAH, NY
Compare KRMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KRMD
Koru Medical Systems Inc
|
2.92 | 134.19M | 31.99M | -11.97M | -1.75M | -0.25 |
|
ISRG
Intuitive Surgical Inc
|
492.06 | 176.29B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
231.79 | 66.56B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.87 | 44.95B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
222.05 | 32.62B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
34.09 | 17.41B | 17.28B | 108.00M | 391.00M | 0.20 |
Koru Medical Systems Inc Stock (KRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Sep-07-23 | Initiated | B. Riley Securities | Buy |
| Sep-07-23 | Initiated | Lake Street | Buy |
| Nov-10-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-10-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-26-21 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-26-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-10-20 | Initiated | H.C. Wainwright | Buy |
| Jul-16-20 | Initiated | Canaccord Genuity | Buy |
| Jun-24-20 | Initiated | Piper Sandler | Overweight |
View All
Koru Medical Systems Inc Stock (KRMD) Latest News
KORU Medical Systems (NASDAQ:KRMD) Upgraded at B. Riley - Defense World
KORU Medical Systems revenues increase 23% to USD 8.8M in Q4 2024 - Medical Buyer
Repro-Med Systems’ Earnings Call Highlights Growth and Challenges - TipRanks
KORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2024 Earnings Call Transcript - Insider Monkey
KORU Medical Systems Inc (KRMD) Q4 2024 Earnings Call Highlights: Record Revenues and Strategic ... - Yahoo Finance
KORU Medical Systems Inc (KRMD) Q4 2024 Earnings Call Highlights: Record Revenues and Strategic Expansions - GuruFocus.com
KORU Medical Systems Reports Record 2024 Financial Results - TipRanks
Earnings call transcript: KORU Medical’s Q4 2024 beats EPS estimates, stock dips - Investing.com India
KORU Medical Systems Inc reports results for the quarter ended December 31Earnings Summary - TradingView
KORU Medical Systems, Inc. SEC 10-K Report - TradingView
KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance - Joplin Globe
KORU Medical Systems earnings beat, revenue topped estimates By Investing.com - Investing.com Canada
Y Intercept Hong Kong Ltd Takes Position in KORU Medical Systems, Inc. (NASDAQ:KRMD) - Defense World
KORU Medical Systems (KRMD) Projected to Post Earnings on Wednesday - Defense World
KORU Medical Systems, Inc. (KRMD): A Bull Case Theory - MSN
Head-To-Head Contrast: KORU Medical Systems (NASDAQ:KRMD) & Autonomix Medical (NASDAQ:AMIX) - Defense World
KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 - WICZ
When Will KORU Medical Reveal Its Q4 Performance? Key Date Announced - StockTitan
KORU Medical Systems (NASDAQ:KRMD) Earns Neutral Rating from Piper Sandler - MarketBeat
Piper Sandler cuts Koru Medical stock rating to neutral - MSN
KORU downgraded by Piper Sandler on valuation - MSN
KORU Medical Systems downgraded to “Neutral” at Piper Sandler - TradingPedia
KORU Medical Systems (NASDAQ:KRMD) Earns “Neutral” Rating from Piper Sandler - Defense World
KORU Medical Systems' Shares Fall After Downgrade From Piper Sandler -February 14, 2025 at 02:32 pm EST - Marketscreener.com
This Informatica Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
Piper Sandler Downgrades KORU Medical Systems to Neutral From Overweight, $4.50 Price Target - Marketscreener.com
KORU Medical Systems Inc. (KRMD) is a Great Momentum Stock: Should You Buy? - MSN
KORU Medical Systems Has A Long Runway (NASDAQ:KRMD) - Seeking Alpha
Calamos Advisors LLC Purchases New Shares in KORU Medical Systems, Inc. (NASDAQ:KRMD) - MarketBeat
KORU Medical Systems signs agreement for subcutaneous immunoglobulin infusion system - MSN
Koru Medical inks deal to develop next-gen subcutaneous infusion system - Drug Delivery Business News
Financial Metrics Exploration: Understanding KORU Medical Systems Inc (KRMD) Through Ratios - The Dwinnex
Revolutionary SCIg Therapy Innovation: KORU Medical and SCHOTT Join Forces to Transform Home Infusion - StockTitan
KORU Medical Systems Inc (KRMD)’s highs and lows: A closer look at its stock price fluctuations - US Post News
KRMD’s Market Whiplash: 19.48% YTD Rise, 18.40% Rise in 30 Days - The InvestChronicle
KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology - Marketscreener.com
KORU Medical partners for Phase III trial in rare kidney disorder - Investing.com Canada
Major Breakthrough: KORU Medical Targets 30,000 Patient Market with Revolutionary Kidney Treatment Trial - StockTitan
Albion Financial Group UT Has $2.18 Million Stock Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD) - MarketBeat
KORU Medical Systems (NASDAQ:KRMD) Price Target Raised to $6.00 - Defense World
KORU Medical Systems, Inc. (NASDAQ:KRMD) Short Interest Update - MarketBeat
Craig Hallum Raises KORU Medical Systems (NASDAQ:KRMD) Price Target to $6.00 - MarketBeat
Koru Medical stock price target raised, buy rating on strong period - Investing.com Australia
Analyst Expectations For KORU Medical Systems's Future - Benzinga
Koru Medical stock price target raised, buy rating on strong period By Investing.com - Investing.com South Africa
What is B. Riley’s Estimate for KRMD FY2024 Earnings? - Defense World
Koru Medical Systems Inc Stock (KRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):